CompletedNot Applicable

Guided Imagery for Military Sexual Trauma-Related Posttraumatic Stress Disorder (PTSD)

United States40 participantsStarted 2007-10

Plain-language summary

Military sexual trauma (MST) is a significant women's mental health issue. There is a crucial need for effective therapies for MST-related posttraumatic stress disorder (PTSD) that are well-tolerated and can be flexibly administered in a variety of treatment settings. Guided imagery is a novel, transportable intervention technique that meets these requirements and warrants research in PTSD. The proposed study will be a randomized controlled trial of the Guided Imagery for Trauma (GIFT) intervention for women veterans with MST-related PTSD. This minimal contact intervention is designed to increase coping, affect management and relaxation skills, and to fostering more positive images and beliefs associated with surviving trauma. The feasibility and tolerability of GIFT have already been demonstrated in an open-label pilot of 15 women veterans with MST-related PTSD, with very promising initial results.

Who can participate

Age range18 Years – 65 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Age 18-65
✓. Status as a women veteran
✓. Receives care at the Durham VAMC
✓. History of MST, confirmed by CAPS interview
✓. DSM-IV diagnosis of PTSD, confirmed by CAPS interview
✓. Able to participate in a research interview in English.
✓. Regular telephone access

Exclusion criteria

✕. Current diagnosis of organic, psychotic, or bipolar disorder
✕. Suicidality or parasuicidality
✕. Ongoing family violence
✕. Alcohol or drug abuse within previous 3 months
✕. Enrolled in cognitive-behavioral/exposure-based therapy for PTSD during study period. Supportive therapy and some psychiatric medications (if stabilized at least 3 months prior to enrollment) are acceptable. Although patients may use medications, no new medications will be started during the study. This includes, but is not restricted to, SSRIs, benzodiazepines, barbiturates, antiepileptic drugs, antidepressants, buspirone, non-benzodiazepine hypnotics, stimulants, or antipsychotics.

What they're measuring

PTSD Severity - Clinician Administered PTSD Scale (CAPS)

Timeframe: Midpoint and Endpoint

Trial details

NCT IDNCT00635635

SponsorDuke University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-03

View on ClinicalTrials.gov More Stress Disorder, Post Traumatic trials